Back to top
more

HealthEquity (HQY)

(Real Time Quote from BATS)

$79.21 USD

79.21
250,981

+0.62 (0.79%)

Updated Sep 20, 2024 11:12 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (162 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks.com featured highlights include TAL Education, The RealReal, DarioHealth, HealthEquity and Energous

by Zacks Equity Research

TAL Education, The RealReal, DarioHealth, HealthEquity and Energous have been highlighted in this Screen of The Week article.

Sanghamitra Saha headshot

Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios. These stocks include TAL Education Group (TAL), The RealReal (REAL), DarioHealth (DRIO), HealthEquity (HQY) and Energous (WATT).

Cigna's Health Benefits Unit Launches a New E-Treatment Option

by Zacks Equity Research

CI's new launch, a new E-Treatment option, is expected to improve patient satisfaction and operational efficiency.

Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HQY vs. MEDP: Which Stock Is the Better Value Option?

by Zacks Equity Research

HQY vs. MEDP: Which Stock Is the Better Value Option?

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

by Zacks Equity Research

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HealthEquity Stock May Gain From Its Latest Partnership With Paytient

by Zacks Equity Research

HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.

HealthEquity Stock Rises on Q2 Earnings and Revenue Beat

by Zacks Equity Research

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

HealthEquity (HQY) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

HealthEquity (HQY) delivered earnings and revenue surprises of 22.86% and 5.43%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

The Cooper Companies (COO) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

The Cooper Companies (COO) delivered earnings and revenue surprises of 5.49% and 0.57%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q2 Earnings

by Zacks Equity Research

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended July 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Is HealthEquity Stock a Hold Now Amid Strong Top-Line Growth?

by Zacks Equity Research

HQY's sustained strength in HSAs raises optimism about the stock.

Quest Diagnostics' (DGX) New Deal Aids Diagnostic Access in Ohio

by Zacks Equity Research

Quest Diagnostics (DGX) signs an agreement to acquire select assets of University Hospitals' outreach laboratory services business.

Here's Why HealthEquity (HQY) is a Strong Growth Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

IceCure Medical Ltd. (ICCM) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

IceCure Medical (ICCM) delivered earnings and revenue surprises of 14.29% and 12.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Embecta Corp. (EMBC) delivered earnings and revenue surprises of 54.17% and 0.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Natera (NTRA) delivered earnings and revenue surprises of 56.52% and 21.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now

by Zacks Equity Research

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

Here's Why HealthEquity (HQY) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain HealthEquity (HQY) Stock for Now

by Zacks Equity Research

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.